Greenwich Lifesciences Inc (GLSI)

$29.02 +2.19 (8.16%)
Market Cap 371.73M
Revenue (ttm) 0.00
Net Income (ttm) -15.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 684,400
Avg Vol 405,020
Day's Range N/A - N/A
Shares Out 13.86M
Stochastic %K 88%
Beta 1.47
Analysts Strong Sell
Price Target $47.50

Company Profile

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company also develops FLAMINGO-01, which is in Phase III clinical trial designed to evaluate the safety and efficacy...

Industry: Biotechnology
Sector: Healthcare
Phone: 832 819 3232
Address:
Building 14, 3992 Bluebonnet Dr., Stafford, United States
Lukeing_At_Stocks
Lukeing_At_Stocks Jan. 14 at 2:33 PM
$GLSI 👍👍
0 · Reply
skiddy5
skiddy5 Jan. 14 at 1:44 PM
$GLSI bad news here is it ran up so much there is only 400% upside left in the near term.
1 · Reply
Alwaysdiversify
Alwaysdiversify Jan. 14 at 1:37 PM
$GLSI Now here's some optimism for you......Right now there are sell orders for 2,500 and 500 shares at $200 and $500, respectively. Clearly someone(s) does not want to be caught sleeping when news breaks!
1 · Reply
Avocado_smash
Avocado_smash Jan. 14 at 1:36 PM
$GLSI PT: 31.80 - 37.75++ Open, trade and closed below that range, pullback might start.
0 · Reply
Alwaysdiversify
Alwaysdiversify Jan. 14 at 1:33 PM
$GLSI Looking good to set a new 52-week high today. My Schwab account right now showing a bid/ask spread of $29.10 and $30.25. Resistance at $30.50 with Level 2 showing 5K shares parked there now. Chew through that, and this will close above $31 today imho.
0 · Reply
mshah1615
mshah1615 Jan. 14 at 1:18 PM
$GLSI Looks like there is short covering started yesterday.First time the borrowings rate come down.On etrade it drop from 242 to 158
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jan. 14 at 1:10 PM
$GLSI CEO purchased 2,900 shares at $27.54 for a total of $79,866. Patel Snehal now owns 5,602,302 shares. https://ceo-buys.com
0 · Reply
SocioCobb
SocioCobb Jan. 14 at 1:04 PM
$GLSI Patel is my hero...
0 · Reply
Hbhatwala
Hbhatwala Jan. 14 at 12:08 PM
$GLSI Looks like Bossman PATEL read my thread of 134 shares per member and bought 2700 to help us out. Members buy what you can but keep adding 134 shares per member it will squeeze the shorties. Flamingo beast 🦩🦩🦩🦩🦩🦩🚀🚀🚀🚀🚀🚀🚀
0 · Reply
Kamal2020
Kamal2020 Jan. 14 at 12:06 PM
$GLSI Snehal keeps buying regardless of price, reflecting strong long-term confidence and little concern for short-term price movements.
0 · Reply
Latest News on GLSI
Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

Dec 29, 2025, 6:00 AM EST - 16 days ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to September 30, 2026

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Dec 22, 2025, 6:00 AM EST - 23 days ago

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?

Dec 15, 2025, 11:11 AM EST - 4 weeks ago

Why Is Greenwich LifeSciences Stock Surging After Data From Breast Cancer Vaccine?

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Dec 15, 2025, 6:00 AM EST - 4 weeks ago

Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Dec 8, 2025, 6:00 AM EST - 5 weeks ago

Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

Dec 3, 2025, 6:00 AM EST - 6 weeks ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

Oct 9, 2025, 6:00 AM EDT - 3 months ago

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Oct 2, 2025, 6:00 AM EDT - 3 months ago

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

Sep 30, 2025, 6:00 AM EDT - 3 months ago

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Sep 18, 2025, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation

Sep 10, 2025, 6:00 AM EDT - 4 months ago

Greenwich LifeSciences' GLSI-100 Granted US FDA Fast Track Designation

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Aug 20, 2025, 9:25 AM EDT - 5 months ago

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

Aug 19, 2025, 6:00 AM EDT - 5 months ago

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

Aug 13, 2025, 6:00 AM EDT - 5 months ago

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Aug 11, 2025, 6:00 AM EDT - 5 months ago

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 3, 2025, 8:00 AM EDT - 10 months ago

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Apr 2, 2025, 6:00 AM EDT - 10 months ago

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

Mar 27, 2025, 6:00 AM EDT - 10 months ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

Mar 17, 2025, 6:45 AM EDT - 10 months ago

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

Feb 10, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe

Jan 29, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

Jan 27, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

Jan 23, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01

Greenwich LifeSciences Provides Update on Commercial Manufacturing

Jan 22, 2025, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Commercial Manufacturing

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI)

Jan 17, 2025, 8:20 AM EST - 1 year ago

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI)

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

Jan 14, 2025, 6:15 AM EST - 1 year ago

Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01

Greenwich LifeSciences Partners with GIM in Italy

Nov 26, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Partners with GIM in Italy

Greenwich LifeSciences Provides Update on Corporate Events

Nov 18, 2024, 6:00 AM EST - 1 year ago

Greenwich LifeSciences Provides Update on Corporate Events

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

Aug 1, 2024, 6:00 AM EDT - 1 year ago

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100

Jun 26, 2024, 2:05 PM EDT - 1 year ago

Greenwich LifeSciences: Halting Of Breast Cancer Recurrence With GLSI-100

Greenwich LifeSciences Set to Join Russell 2000 Index Again

Jun 26, 2024, 7:33 AM EDT - 1 year ago

Greenwich LifeSciences Set to Join Russell 2000 Index Again

Greenwich LifeSciences Announces $2.5 Million Private Placement

Jun 14, 2024, 6:00 AM EDT - 1 year ago

Greenwich LifeSciences Announces $2.5 Million Private Placement

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Mar 13, 2024, 6:00 AM EDT - 2 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Mar 12, 2024, 6:00 AM EDT - 2 years ago

Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

Feb 27, 2024, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

Feb 22, 2024, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Feb 14, 2024, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

Nov 21, 2023, 6:00 AM EST - 2 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024

Greenwich LifeSciences Provides Year End Update

Dec 29, 2022, 6:48 AM EST - 3 years ago

Greenwich LifeSciences Provides Year End Update

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

Dec 1, 2022, 6:00 AM EST - 3 years ago

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

Greenwich LifeSciences: Persevering CEO And Interesting Data

Sep 6, 2022, 5:40 PM EDT - 3 years ago

Greenwich LifeSciences: Persevering CEO And Interesting Data

Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial

Aug 11, 2022, 10:30 AM EDT - 3 years ago

Greenwich LifeSciences Announces Activation of Clinical Sites and Commencement of Phase III Clinical Trial

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

Aug 3, 2022, 8:00 AM EDT - 3 years ago

Greenwich LifeSciences Provides Updates on Flamingo-01 Phase III Clinical Trial

Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Jul 28, 2022, 6:00 AM EDT - 3 years ago

Greenwich LifeSciences Provides Financing Strategy & Corporate Update

Here's Why Greenwich Lifesciences Shares Are Popping Off Today

Jul 12, 2022, 1:18 PM EDT - 3 years ago

Here's Why Greenwich Lifesciences Shares Are Popping Off Today

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

Jul 12, 2022, 6:00 AM EDT - 3 years ago

Greenwich LifeSciences Announces Removal of Clinical Hold Permitting Phase III Clinical Trial to Proceed

Greenwich LifeSciences Announces Suspension of Share Repurchase Program

Jul 11, 2022, 4:15 PM EDT - 3 years ago

Greenwich LifeSciences Announces Suspension of Share Repurchase Program

Greenwich LifeSciences to Resume Stock Repurchase Program

May 23, 2022, 7:00 AM EDT - 3 years ago

Greenwich LifeSciences to Resume Stock Repurchase Program

Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting

May 23, 2022, 6:00 AM EDT - 3 years ago

Greenwich LifeSciences Provides Updates on Upcoming Phase III Clinical Trial & ASCO Meeting

Greenwich LifeSciences: A First Look

May 19, 2022, 11:12 AM EDT - 3 years ago

Greenwich LifeSciences: A First Look

Lukeing_At_Stocks
Lukeing_At_Stocks Jan. 14 at 2:33 PM
$GLSI 👍👍
0 · Reply
skiddy5
skiddy5 Jan. 14 at 1:44 PM
$GLSI bad news here is it ran up so much there is only 400% upside left in the near term.
1 · Reply
Alwaysdiversify
Alwaysdiversify Jan. 14 at 1:37 PM
$GLSI Now here's some optimism for you......Right now there are sell orders for 2,500 and 500 shares at $200 and $500, respectively. Clearly someone(s) does not want to be caught sleeping when news breaks!
1 · Reply
Avocado_smash
Avocado_smash Jan. 14 at 1:36 PM
$GLSI PT: 31.80 - 37.75++ Open, trade and closed below that range, pullback might start.
0 · Reply
Alwaysdiversify
Alwaysdiversify Jan. 14 at 1:33 PM
$GLSI Looking good to set a new 52-week high today. My Schwab account right now showing a bid/ask spread of $29.10 and $30.25. Resistance at $30.50 with Level 2 showing 5K shares parked there now. Chew through that, and this will close above $31 today imho.
0 · Reply
mshah1615
mshah1615 Jan. 14 at 1:18 PM
$GLSI Looks like there is short covering started yesterday.First time the borrowings rate come down.On etrade it drop from 242 to 158
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jan. 14 at 1:10 PM
$GLSI CEO purchased 2,900 shares at $27.54 for a total of $79,866. Patel Snehal now owns 5,602,302 shares. https://ceo-buys.com
0 · Reply
SocioCobb
SocioCobb Jan. 14 at 1:04 PM
$GLSI Patel is my hero...
0 · Reply
Hbhatwala
Hbhatwala Jan. 14 at 12:08 PM
$GLSI Looks like Bossman PATEL read my thread of 134 shares per member and bought 2700 to help us out. Members buy what you can but keep adding 134 shares per member it will squeeze the shorties. Flamingo beast 🦩🦩🦩🦩🦩🦩🚀🚀🚀🚀🚀🚀🚀
0 · Reply
Kamal2020
Kamal2020 Jan. 14 at 12:06 PM
$GLSI Snehal keeps buying regardless of price, reflecting strong long-term confidence and little concern for short-term price movements.
0 · Reply
Jonathan2121
Jonathan2121 Jan. 14 at 11:28 AM
$GLSI the boss
0 · Reply
HoldGuy_GLSI
HoldGuy_GLSI Jan. 14 at 11:19 AM
$GLSI He is the biggest holder, no reason for any dilution
0 · Reply
Kamal2020
Kamal2020 Jan. 14 at 11:15 AM
$GLSI Snehal at his best again 🫡
0 · Reply
HoldGuy_GLSI
HoldGuy_GLSI Jan. 14 at 11:10 AM
$GLSI
2 · Reply
Jonathan2121
Jonathan2121 Jan. 14 at 10:58 AM
$GLSI
0 · Reply
Kamal2020
Kamal2020 Jan. 14 at 9:48 AM
$GLSI 13.85 million total float, approximately 80% (about 11.08 million shares) is held by insiders. Of the remaining shares, 1.61 million are sold short, leaving only about 1.16 million shares effectively available for retail investors. Shorts > available Float Shorts no way can cover and are going to be burned.
1 · Reply
Cortigent
Cortigent Jan. 14 at 9:43 AM
$GLSI
0 · Reply
Kamal2020
Kamal2020 Jan. 14 at 8:06 AM
$GLSI for new investors to understand about GLSI https://youtu.be/LmzfEDUpZWM
1 · Reply
Odenham
Odenham Jan. 14 at 8:03 AM
$GLSI
0 · Reply
Kamal2020
Kamal2020 Jan. 14 at 7:56 AM
$GLSI Another junk ready to loose money 🫡
1 · Reply
WolfSK
WolfSK Jan. 14 at 7:29 AM
$GLSI with 60-70% of float tied up and all shorts underwater at this level (we are at 4 year high) this is a key time. 20% of float is short. They are in deep trouble. Any sensible short will have a stop loss at 52 week high in late 30. Break that and we could go straight to mid and late 30’s. Lets make it happen longs. Get your buys in and make them pay! :)
0 · Reply
D0ntBeLeaveMeResearch
D0ntBeLeaveMeResearch Jan. 14 at 5:02 AM
$GLSI
0 · Reply